Journal Guide

Phytomedicine is published to attract and disseminate innovative and expert findings in the fields of phytopharmacology, phytotherapy and phytotoxicology, as a reference source for researchers in these fields, and with the aim to set international standards in their methodology. The journal publishes research results on phytotherapy (clinical trials), phytopharmacology, pharmacognosy, standardization and phytotoxicology, obtained with plant extracts as well as isolated compounds from these extracts and phytopharmaceuticals. Phytomedicine is targeted towards papers of a practical nature. The papers published in this journal are also useful to drug regulatory authorities in deciding whether to approve certain phytomedicines or not. Phytomedicine consists of the following sections: Case reports, Pharmacological and molecularbiological studies, Screening studies (only when focused on plant extracts or isolated compounds with extraordinary activities, Chemical structure - activity studies, Chemical analysis and standardization of plant drugs and phytopharmaceuticals, Reviews (by invitation).

Planta Medica is one of the leading international journals in the field of medicinal plants and natural products with original research papers, letters, rapid communications, reviews, minireviews and perspectives from researchers worldwide. From 2011 Planta Medica will publish 18 issues per year.The following areas of medicinal plants and natural products are covered:* Biological and Pharmacological Activity* Pharmacokinetic and Clinical Studies* Natural Product Chemistry* Analytical Studies.

Conference proceedings are accepted for publication in Procedia in Vaccinology based on suitability and are required to meet certain criteria, including relevance to an international audience and covering highly cited or timely topics. Procedia in Vaccinology will cover proceedings in all topics related to vaccines and vaccination.

What does Procedia in Vaccinology offer authors and conferences organizers?
Procedia in Vaccinology offers a single, highly recognized platform where conference papers can be hosted and accessed by millions of researchers. Authors then know where to go to keep abreast of the latest developments in their field. All proceedings appear online, on Science Direct, within 8 weeks of acceptance of the final manuscripts via the conference organizer and are freely available to all users. Procedia in Vaccinology offers authors and conference organizers a fast and cost effective way to provide maximum exposure for their papers.

Word templates are provided to assist in the publication and the final online papers contain linked references, XML versions and DOI numbers.

Why should conference organizers choose Procedia in Vaccinology?
Unlike regular journals, there is no limit to the amount of papers a Procedia in Vaccinology issue can contain and pricing is affordable, clear and transparent. Procedia in Vaccinology offers immediate access for all, with papers online within 8 weeks of acceptance, and free access providing maximum exposure for individual papers and the related conference. Organizers are credited on the actual issue and are fully responsible for quality control, the review process and the content of individual conference papers.

What is the process for submitting conference proceedings to Procedia in Vaccinology?
Proposals, including a synopsis of why such a Procedia in Vaccinology issue will have an impact on its community, a list of agreed contributors and an outline of the related conference (including a link to the conference website) should be sent to:

Alina Helsloot
Executive Publisher
a.helsloot@elsevier.com

Proposals should be prepared using the template /inca/publications/misc/PROVAC Proposal Template.dochere.

Please note that we do not accept proposals from individual authors for Procedia titles.

What are the costs associated with Procedia in Vaccinology?
There is an agreed fee, based on the size of the proceedings, which includes online publication on http://www.sciencedirect.comScienceDirect and free access after acceptance. In addition to the online version there is the possibility to purchase paper copies, CD-ROMs and USB sticks. Moreover, interactive media possibilities such as webcasts and web seminars can be acquired for extra exposure both before and after the conference.

Can Procedia in Vaccinology be sponsored?
We are open to discussing sponsoring possibilities at all times. Sponsors can include funding bodies, government agencies and/or industry. Benefits to sponsors include visibility amongst a scientific audience and the opportunity to communicate messages via a peer-reviewed platform. Benefits to authors and conference organizers are the further dissemination of material to an international audience and reduced costs to the overall conference budget.

At the heart of open access for the global chemistry community. RSC Advances publishes advances in chemistry, and in topics of interest to the chemistry community.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Research published in RSC Pharmaceutics promotes step-change science in the field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on the field. Research sharing new scientific findings from across the areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed. Topics include but are not limited to: • Formulation and design of medicines • Design and characterization of correct dosage forms • Physicochemical and biological properties of drugs and their carriers • Drug delivery devices and their mechanisms of release

Recent Patents on Drug Delivery & Formulation publishes editorials, full-length research articles, short technical notes and guest-edited issues from the academia, industry, and regulatory agencies worldwide, and reviews and mini-reviews with a sharper focus on selected recent patents and patent applications. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science, which include but are not limited to, pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling, and intellectual property. Journal’s ambition is to serve as a bridge between academia and industry to stimulate the development of innovative technologies and products for various applications in the field of pharmaceutical and biotechnology sciences.

Research in Social and Administrative Pharmacy (RSAP) publishes bi-monthly/six times per year, featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.RSAP strives to become a widely recognized venue for publishing articles that proffer new models to guide existing research, make methodological arguments, or otherwise describe the results of rigorous theory-building research. Papers that translate the results of such research into information useful for practitioners are also welcome. RSAP encourages submission of manuscripts from multi-disciplinary collaborators on projects whose goal is to address medication use policy. RSAP also publishes special thematic issues that will be of interest and benefit to its readers and to the community at large.

All papers published in Results in Pharma Sciences have undergone full peer review and must be:

• Scientifically sound
• In compliance with international research and publishing ethics
• Written in clear, concise and correct English
• A valid, contribution to the existing literature and of educational value to the specific community and readers
• Not previously published material

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/725997/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to attract, disseminate and discuss research and contemporary health care issues and link knowledge to practice. Our vision is to become a leading journal for the application of research and knowledge into pharmacy practice. CPJ is published 6 times per year, with the addition of supplements on specific clinical topics. Both original research and review papers pertaining to clinical, social, regulatory, historical and business topics will be considered for publication. News of interest to the profession, opinion pieces and descriptions of innovative practice models are also welcome.

The Saudi Pharmaceutical Journal is published every three months by the Saudi Pharmaceutical Society, with the cooperation of the College of Pharmacy, King Saud University. The Journal accepts high quality articles that conform to its scope and editorial standards. The scope encompasses various disciplines of pharmaceutical sciences and related clinical subjects that are of interest to practicing pharmacists and other health care professionals. The journal will publish original research articles, review articles, short communications, case studies, letters to the editors and book reviews. Abstracts of meetings and symposia will also be considered for publication. All submitted papers are subject to an extensive review by the editorial board and by a panel of international referees.To minimize delays between manuscript submission, decision and publication, authors are requested to follow the "Instructions to authors" found elsewhere in this Journal. Conforming with all the steps listed in that section will facilitate the processing of your manuscript by the Editorial Board.Accredited as a refereed Journal by the Scientific Council of King Saud University, Riyadh, Kingdom of Saudi Arabia.

Scientia Pharmaceutica publishes original research papers, short communications and a limited number of reviews on all fields of pharmaceutical sciences and related areas, as well as on pharmaceutical practice.